SCPX — Scorpius Holdings Share Price
0.000.00%
Last trade - 00:00- $5.66m
- $6.62m
- $6.38m
- 10
- 56
- 27
- 22
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.16 | ||
| Price to Tang. Book | 0.16 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.94 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -107.06% | ||
| Return on Equity | -77.31% | ||
| Operating Margin | -1669.66% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 5.79 | 3.05 | 2.95 | 2.11 | 6.38 | 4.9 | 20.6 | 33.24% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Scorpius Holdings, Inc., formerly NightHawk Biosciences, Inc., is an integrated contract development and manufacturing company. The Company is focused on advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio, Texas. Its analytical services include development of a comprehensive range of analytical test methods to characterize complex biologics, including cell therapy-based products, protein therapeutics, vaccines and advanced therapies. Its Clinical Biomanufacturing includes cGMP Mammalian Cell Culture, and cGMP Microbial Fermentation. Its San Antonio facility is focused on the commercial-scale manufacturing of biodefense-focused molecules and biologics therapeutics. Its biomanufacturing services focus on accelerating product development timelines from pre-clinical evaluation to first-in-human studies.
Directors
- Jeffrey Wolf CHM (57)
- William Ostrander CFO (53)
- John Prendergast LED (67)
- John Monahan IND (74)
- Edward Smith IND (46)
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- June 10th, 2008
- Public Since
- July 24th, 2013
- No. of Shareholders
- 28
- No. of Employees
- 77
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- NYSE MKT
- Shares in Issue
- 36,031,964
- Address
- 627 DAVIS DRIVE, SUITE 400, MORRISVILLE, 27560
- Web
- https://www.nighthawkbio.com/
- Phone
- +1 9192407133
- Auditors
- BDO USA, LLP
Upcoming Events for SCPX
Q2 2024 NightHawk Biosciences Inc Earnings Release
NightHawk Biosciences Inc Annual Shareholders Meeting
Similar to SCPX
FAQ
What is the Scorpius Holdings share price?
As of Today at 19:19 UTC, shares in Scorpius Holdings are trading at $0.16. This share price information is delayed by 15 minutes.
How has the Scorpius Holdings share price performed this year?
Shares in Scorpius Holdings last closed at $0.16 and the price had moved by -79.37% over the past 365 days. In terms of relative price strength the Scorpius Holdings share price has underperformed the S&P500 Index by -82.83% over the past year.
What are the analyst and broker recommendations for Scorpius Holdings?
The overall consensus recommendation for Scorpius Holdings is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Scorpius Holdings dividend yield?
Scorpius Holdings does not currently pay a dividend.
Does Scorpius Holdings pay a dividend?
Scorpius Holdings does not currently pay a dividend.
When does Scorpius Holdings next pay dividends?
Scorpius Holdings does not currently pay a dividend.
How do I buy Scorpius Holdings shares?
To buy shares in Scorpius Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Scorpius Holdings?
As of the previous close price of $0.16, shares in Scorpius Holdings had a market capitalisation of $5.66m.
Where are Scorpius Holdings shares listed?
Here are the trading details for Scorpius Holdings:
- Country of listing: United States
- Exchange: ASQ
- Ticker Symbol: SCPX
What kind of share is Scorpius Holdings?
Based on an overall assessment of its quality, value and momentum Scorpius Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Scorpius Holdings share price forecast for 2024?
The analyst consensus target price for shares in Scorpius Holdings is $10.00. That is 6269.43% above the last closing price of $0.16.
Analysts covering Scorpius Holdings currently have a consensus Earnings Per Share (EPS) forecast of -$1.58 for the next financial year.
What is the trend in the Scorpius Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Scorpius Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -67.88%.
As of the last closing price of $0.16, shares in Scorpius Holdings were trading -63.13% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Scorpius Holdings PE Ratio?
The Scorpius Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.16.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Scorpius Holdings?
Scorpius Holdings' management team is headed by:
- Jeffrey Wolf - CHM
- William Ostrander - CFO
- John Prendergast - LED
- John Monahan - IND
- Edward Smith - IND